Press release from Business Wire India
Source: GlaxoSmithKline Pharmaceuticals Limited
Wednesday, August 10, 2011 07:35 PM IST (02:05 PM GMT)
Editors: General: Consumer interest, Economy; Business: Banking & financial services, Business services, Financial Analyst, Healthcare, biotechnology & pharmaceutical, Stock exchanges; Healthcare
--------------------------------------------------
GlaxoSmithKline Pharmaceuticals Net Sales up 13% in Second Quarter of FY 2011
Mumbai, Maharashtra, India, Wednesday, August 10, 2011 -- (Business Wire India) -- GlaxoSmithKline Pharmaceuticals Limited has announced its financial results for the second quarter ended 30th June 2011. While the net Sales grew by 13%, Sales of the core Pharmaceuticals and vaccines business grew by 14%. Profit After tax (before Exceptionals) grew by 9% during the quarter, and the Operating Profit margin was maintained at 35% in line with the first quarter of 2011. Planned investments in field force expansion for the year continued during the quarter.
Commenting on the performance during the quarter, Dr. Hasit B. Joshipura, Managing Director, said, "The Company's growth has been in line with the market growth. In particular, Oncology, Dermatologicals and Mass Specialty therapies have grown well. In addition to the base effect, vaccines has shown strong market competitive growth."
Apart from two original products from the GSK pipeline in Oncology and Haematology, a branded generic and a product in Stiefel -Dermatology was launched during the quarter.
About GlaxoSmithKline:
GlaxoSmithKline Pharmaceuticals Limited is a subsidiary of GlaxoSmithKline plc, one of the world's leading research-based pharmaceutical and healthcare companies, committed to improving the quality of human life by enabling people to do more, feel better and live longer.
For more information, visit www.gsk-india.com.
To view the tables, please click on the link given below:
Unaudited Financial Results for the Quarter and Half year ended 30th June 2011
For picture(s)/data to illustrate this release click below:
http://www.BusinessWireIndia.com/attachments/Unaudited Financial Results for the Quarter and Half year ended 30th June 2011.pdf
Unaudited Financial Results for the Quarter and Half year ended 30th June 2011.pdf
CONTACT DETAILS
Sunder Rajan, General Manager - Corporate Communications, GlaxoSmithKline Pharmaceuticals Limited, +91 (22) 24959203, sunder.r.rajan@gsk.com
KEYWORDS
CONSUMER, ECONOMY, BANKING, BUSINESS SERVICES, Financial Analyst, HEALTHCARE, STOCK EXCHANGES, HEALTHCARE
If you wish to change your Business Wire India selection please click on this link http://www.businesswireindia.com/media/news.asp and use your personal username and password to login.
Submit your press release at http://www.businesswireindia.com
No comments:
Post a Comment